FDA Recall D-0249-2022
Bayer Healthcare Pharmaceuticals Inc. · Whippany, NJ
Class I — life-threatening Terminated 633 days on record
Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.
Product
Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 58720 6, NDC 11523-0010-2.
Reason for recall
Chemical Contamination: presence of benzene
Recall record
- Recall number
D-0249-2022- Classification
- Class I
- Status
- Terminated
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Press Release
- Distribution
- Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.
- Recall initiated
- 2021-10-01
- Classified by FDA Center
- 2021-11-18
- FDA published
- 2021-11-24
- Terminated
- 2023-06-26
- Recalling firm
- Bayer Healthcare Pharmaceuticals Inc.
- Firm location
- Whippany, NJ
Drug identification
- Brand name(s)
- LOTRIMIN DAILY PREVENTION DEO
- Generic name(s)
- TOLNAFTATE
- Manufacturer(s)
- Bayer HealthCare LLC.
- NDC(s)
11523-0010- Route(s)
- TOPICAL